Results for this period
Full year1 April 2025–31 March 2026Non-consolidated (standalone)Japanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
The spread of highly pathogenic avian influenza, which kept egg prices firm, revisions to selling prices, and the Company's focus on expanding sales of differentiated eggs.
No applicable matters.
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Non-consolidated (standalone) |
| Period Covered | 1 April 2025–31 March 2026 |
| Net Sales | ¥23,107 million (YoY +19.1%) |
| Operating profit | ¥4,965 million (YoY +157.8%) |
| Ordinary income | ¥5,046 million (YoY +152.2%) |
| Profit attributable to owners of the parent | ¥3,862 million (YoY +77.0%) |
| Net income per share | ¥456.65 |
| Operating Margin | 21.5% |
| Equity ratio | End of the current fiscal period 74.9 / End of previous period 73.7 |
| Total assets | ¥23,402 million |
| Net assets | ¥17,518 million |
| Cash flows from operating activities | ¥6,087 million |
| Cash flows from investing activities | ¥-2,065 million |
| Cash flows from financing activities | ¥-911 million |
| Cash and cash equivalents at end of period | ¥7,304 million |
| Full-year earnings forecast | Net Sales ¥22,500 million (YoY -2.6%) / Operating profit ¥3,330 million (YoY -32.9%) / Ordinary income ¥3,410 million (YoY -32.4%) / Net income ¥2,270 million (YoY -41.2%) |
| Annual Dividend Forecast | ¥130 → ¥80（-38.5%） |
| Payout ratio | Current fiscal year 28.5 % / Next-year forecast 29.8 % |
| Shareholder Return Policy | Target payout ratio of approximately 30% |
| Depreciation and amortization | ¥1,165 million |
| Breakdown of extraordinary income (loss) | Extraordinary income Item Gain on sale of non-current assets / Amount ¥0 million, Item Insurance proceeds received / Amount ¥1 million, Item Government subsidies / Amount ¥117 million, Item Livestock epidemic prevention mutual aid payment / Amount ¥209 million, Item Refund from the egg price stabilization fund / Amount ¥249 million, Item Total extraordinary income / Amount ¥578 million / Extraordinary loss Item Loss on sale of fixed assets / Amount ¥0 million, Item Loss on Disposal of Fixed Assets / Amount ¥137 million, Item Settlement Payments / Amount ¥80 million, Item Other / Amount ¥1 million, Item Total extraordinary loss / Amount ¥218 million |
| Disclosure regarding the going concern assumption | No applicable matters. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Material subsequent events | No applicable matters. |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | No (no attendees specified) |
| Issued Shares at Period-End | 8,459,000 |
| Treasury Shares at Period-End | 162 |
| Factors Behind Changes in Business Performance | The spread of highly pathogenic avian influenza, which kept egg prices firm, revisions to selling prices, and the Company's focus on expanding sales of differentiated eggs. |
Items this document does not state (7)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The Company cited firm egg prices resulting from the spread of highly pathogenic avian influenza, revisions to selling prices to address higher logistics and labor costs, and its focus on expanding sales of differentiated eggs. For the next fiscal year, it cited the recovery of supply capacity through the reintroduction of laying hens, a decline in egg prices, foreign exchange rates and grain prices affecting feed costs, and higher logistics and labor costs.